Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 4INDUSTRY 4OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Urinary Bladder Neoplasms 2Thrombosis 1Supratentorial Brain Tumor 1Pain, Postoperative 1Ovarian Neoplasms 1Inflammation 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Arthritis, Rheumatoid 1Anemia 1

Interventions

apatinib 3pembrolizumab 2Poly(ADP-ribose) Polymerase Inhibitors 2Hyperthermic Intraperitoneal Chemotherapy 2Bevacizumab 2taxane 1olaparib 1lenvatinib 1fludarabine 1cediranib 1Whole Genome Sequencing 1Valproic Acid 1Tranexamic Acid 1Tai Ji 1Surgical Procedures, Operative 1Sequence Analysis, RNA 1Saline Solution 1Radiation 1Qigong 1Propranolol 1Positron Emission Tomography Computed Tomography 1Population Groups 1Platinum 1Paclitaxel 1Neoadjuvant Therapy 1Interleukin-2 1Indocyanine Green 1Immunohistochemistry 1Hydralazine 1Gene Expression 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Ovarian Neoplasms × Saline Solution × Clear all
NCT02711865 2016-03-17

Predictive Biomarkers for IGF1R Targeted Therapy in Ovarian Cancer

Hillel Yaffe Medical Center

Unknown
20 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡